Low-dose Mifepristone (25 mg) in Treatment of Uterine Myoma in Perimenopausal Women
Arun Nagrath, Garima Gupta, Shikha Seth, Ekta Singh, AS Mathur
Citation Information :
Nagrath A, Gupta G, Seth S, Singh E, Mathur A. Low-dose Mifepristone (25 mg) in Treatment of Uterine Myoma in Perimenopausal Women. J South Asian Feder Menopause Soc 2013; 1 (1):34-37.
Copyright © 2013; The Author(s).
Hysterectomy in the United States, 1988-1990. Obstet Gynecol 1994;83(4):549-55.
Twelve month safety and efficacy of low-dose mifepristone for uterine myomas. J Minim Invasive Gynecol 2005 May- Jun; 12(3):227-33.
Clinical efficacy of the antiprogesterone RU486 in the treatment of endometriosis and uterine fibroids. Hum Reprod 1994;9:116-20.
Effect of mifepristone for symptomatic leiomyomata on quality of life and uterine size: A randomized controlled trial. Obstet Gynecol 2006;108:1381-87.
Mifepristone for treatment of uterine leiomyoma, A prospective randomized placebo cotrolled trial. Human Reproduction 2009;24(8):1870-79.
Regression of uterine leiomyomata in response to the antiprogesterone RU486. J Clin Endocrinol Metab 1993;76: 513-17.
Regression of uterine leiomyomata to the antiprogesterone RU486: Doseresponse effect. Fertil Steril 1995;64:187-90.
Long-term mifepristone (RU486) therapy resulting in massive benign endometrial hyperplasia. Clin Endocrinol 2001;54:399-404.
Systematic review of mifepristone for the treatment of uterine leiomyomata. Obstet Gynecol 2004;103:1331-36.
Mifepristone for treatment of uterine leiomyomas: A randomized controlled trial. Obstet Gynecol 2008 Nov;112(5):1029-36.